Risks of new anticoagulants.

Risks of new anticoagulants. Nurs Older People. 2015 Jun 25;27(6):15 Authors: Abstract Atrial fibrillation is a major cause of stroke and anticoagulation, with warfarin known to decrease the risk. New oral anticoagulants provide patients with a convenient, fixed-dose alternative to warfarin. These novel drugs have been shown to be as effective at stroke prevention but trials showed an unexpected increase in gastrointestinal bleeding. This retrospective study aimed to quantify this risk by comparing the new drugs dabigatran and rivaroxaban with warfarin. They found no difference for younger patients but risk of bleeding increased with the new drugs in people over the age of 65 and was particularly concerning for people aged over 75 years. PMID: 26108939 [PubMed - in process]
Source: Nursing Older People - Category: Nursing Tags: Nurs Older People Source Type: research